Nymox Pharmaceutical Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 45,200 | 0.0484% |
Individual Insiders | 39,215,471 | 42% |
General Public | 54,104,469 | 57.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
33,508,010 | US$11.7m | 0% | no data | |||
4,782,065 | US$1.7m | 0% | no data | |||
925,000 | US$323.6k | 0% | no data | |||
35,100 | US$12.3k | 0% | 0.01% | |||
10,000 | US$3.5k | 0% | no data | |||
396 | US$137.2 | 0% | no data | |||
100 | US$35.9 | 0% | no data |